FLJ22184 Inhibitors
Chemical inhibitors of FLJ22184 include a diverse set of compounds that interfere with the protein's function through various biochemical pathways. Phloretin, a dihydrochalcone found in apple leaves, can disrupt cell membrane interactions essential for FLJ22184 activity by altering the lipid bilayer's structure. This alteration can prevent FLJ22184 from associating with the membrane, thus inhibiting its function. Similarly, PD 98059 targets the MAPK/ERK pathway by selectively inhibiting MEK. Since the MAPK/ERK pathway is a common signaling route within cells, if FLJ22184 is part of this pathway, its function would be inhibited as a result of the reduced downstream signaling. LY294002 works by inhibiting PI3K, and consequently, the AKT pathway's signaling is diminished. If FLJ22184 relies on PI3K-AKT signaling for its activity, its function would be decreased in the presence of LY294002. W-7 Hydrochloride and Bisindolylmaleimide I both act on calcium-dependent processes; W-7 Hydrochloride as a calmodulin antagonist, and Bisindolylmaleimide I as an inhibitor of PKC. These inhibitors can interfere with calcium signaling cascades, which may be crucial for FLJ22184's function.
Oligomycin A inhibits mitochondrial ATP synthase, potentially depleting the energy supply necessary for FLJ22184's activity. Genistein, a tyrosine kinase inhibitor, prevents phosphorylation events that could be essential for FLJ22184's function. Gö 6983, another PKC inhibitor, would further ensure the reduction of PKC-mediated activation of FLJ22184. ML-7 Hydrochloride disrupts the function of myosin light chain kinase, which could affect cytoskeletal dynamics that are potentially important for FLJ22184's function. NF449 specifically inhibits the Gs alpha subunit of G proteins, which, if involved in FLJ22184's signaling, would hinder its activity. KT 5720, by inhibiting PKA, can also prevent the activation or stabilization of FLJ22184 if PKA-mediated phosphorylation is necessary for its function. Lastly, U73122's action on phospholipase C can impede the generation of second messengers like DAG or IP3, which might be required for FLJ22184's activity. Each inhibitor targets a unique aspect of FLJ22184's function, demonstrating the complexity of the regulatory mechanisms that govern protein activity within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $64.00 $255.00 | 13 | |
Phloretin inhibits the function of FLJ22184 by interfering with the protein's ability to interact with cell membranes. As a dihydrochalcone found in apple leaves, phloretin can disrupt the lipid bilayer's structure and thus inhibit membrane-associated proteins. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 selectively inhibits MEK, which is part of the MAPK/ERK pathway. FLJ22184, if involved in this pathway, would be functionally inhibited by the reduction in MAPK/ERK signaling due to MEK inhibition, as downstream signaling necessary for FLJ22184 activity would be compromised. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, and by inhibiting PI3K, it can reduce the downstream signaling of the AKT pathway, which could be critical for the function of FLJ22184. Inhibition of this pathway would lead to a decrease in FLJ22184 function, assuming FLJ22184 requires PI3K-AKT signaling for its activity. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 Hydrochloride acts as a calmodulin antagonist, and by binding to calmodulin, it inhibits the calcium-calmodulin dependent enzymes. If FLJ22184 requires such enzymes for its proper function, the inhibition of these enzymes would lead to a functional inhibition of FLJ22184. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Oligomycin A inhibits the mitochondrial ATP synthase. If FLJ22184 requires ATP from mitochondrial oxidative phosphorylation for its function, inhibition of ATP synthesis by Oligomycin A would result in diminished energy availability for FLJ22184, leading to functional inhibition. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By inhibiting tyrosine kinases, it could prevent the phosphorylation of FLJ22184 if the protein's function is dependent on phosphorylation by such kinases. This lack of phosphorylation would lead to functional inhibition of FLJ22184. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is an inhibitor of Protein Kinase C (PKC). If FLJ22184's activity is reliant on PKC-mediated signaling, inhibiting PKC would result in decreased activation of FLJ22184, hence functionally inhibiting the protein. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a potent and selective inhibitor of PKC. It would functionally inhibit FLJ22184 by reducing PKC-mediated phosphorylation if FLJ22184 is regulated by PKC-dependent phosphorylation, leading to a reduction in FLJ22184 activity. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 Hydrochloride is an inhibitor of myosin light chain kinase (MLCK). If FLJ22184's function is regulated by cytoskeletal dynamics influenced by MLCK activity, inhibition by ML-7 would result in functional inhibition of FLJ22184 by altering the cytoskeletal structure and dynamics. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
NF449 is a potent and selective inhibitor of the Gs alpha subunit of G proteins. If FLJ22184 is involved in G protein-coupled receptor signaling, specifically via the Gs alpha pathway, inhibition by NF449 would lead to reduced Gs alpha activity, thereby functionally inhibiting FLJ22184 by impairing the signaling pathway it is involved in. | ||||||